COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 2253: Articles 22521-22530  | Next

Quantifying the dynamics of COVID-19 burden and impact of interventions in Java, Indonesia
Djaafara, B. A., Whittaker, C., Watson, O. J., Verity, R., Brazeau, N. F., Widyastuti, W., Oktavia, D., Adrian, V., Salama, N., Bhatia, S., Nouvellet, P., Sherrard-Smith, E., Churcher, T. S., Surendra, H., Lina, R. N., Ekawati, L. L., Lestari, K. D., Andrianto, A., Thwaites, G., Baird, J. K., Ghani, A. C., Elyazar, I. R., Walker, P. G.
10.1101/2020.10.02.20198663 — Posted: 2020-10-02
The SARS-CoV-2 effective reproduction rate has a high correlation with a contact index derived from large-scale individual location data using GPS-enabled mobile phones in Germany
Ruediger, S., Konigorski, S., Edelman, J., Zernick, D., Lippert, C., Thieme, A. H.
10.1101/2020.10.02.20188136 — Posted: 2020-10-02
Theta autoregressive neural network model for COVID-19 outbreak predictions
CHAKRABORTY, T., Bhattacharyya, A., Pattnaik, M.
10.1101/2020.10.01.20205021 — Posted: 2020-10-02
Vulnerability to rumors during the COVID-19 pandemic:Results of a national survey
Long, V. J. E., Koh, W. S., Saw, Y. E., Liu, J. C.
10.1101/2020.10.01.20205187 — Posted: 2020-10-02
Oil Immersed Lossless Total Analysis System (OIL-TAS): Integrated RNA Extraction and Detection for SARS-CoV-2 Testing
Juang, D. S., Juang, T. D., Dudley, D. M., Newman, C. M., Friedrich, T. C., O'Connor, D. H., Beebe, D. J.
10.1101/2020.09.30.20204842 — Posted: 2020-10-02
Epidemiological and clinical characteristics of COVID-19 in Brazil using digital technology
Hajar, F. N., Fernandes-Silva, M. M., Pereira da Cunha, G. S., Herrera, G., Hamud, A., Azevedo, V. F.
10.1101/2020.09.30.20204917 — Posted: 2020-10-02
COVID-19 era, Preventive effect of no going out against co-infection of the seasonal influenza virus and SARS-CoV-2
Hayashi, T., Yaegashi, N., Konishi, I.
10.1101/2020.09.27.20202739 — Posted: 2020-10-02
High prevalence of SARS-CoV-2 swab positivity in England during September 2020: interim report of round 5 of REACT-1 study
Riley, S., Ainslie, K. E. C., Eales, O., Walters, C. E., Wang, H., Atchison, C. J., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2020.09.30.20204727 — Posted: 2020-10-02
Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020
Dyrdak, R., Hodcroft, E. B., Wahlund, M., Neher, R. A., Albert, J.
10.1101/2020.10.01.20205096 — Posted: 2020-10-02
Circulating levels of calcitonin gene-related peptide (CGRP) are lower in COVID-19 patients
Ochoa-Callejero, L., Garcia-Sanmartin, J., Villoslada-Blanco, P., Iniguez, M., Perez-Matute, P., Brody, R., Oteo, J. A., Martinez, A.
10.1101/2020.10.01.20205088 — Posted: 2020-10-02 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).